cas 288148-34-5|| where to buy 1-Methyl-1H-pyrazole-4-sulfonyl chloride

Название продукции:1-Methyl-1H-pyrazole-4-sulfonyl chloride

IUPAC Name:1-methyl-1H-pyrazole-4-sulfonyl chloride

: CAS：288148-34-5; Молекулярная формула：C4H5ClN2O2S; Чистота：95%+

Упаковочная единица	Доступно для заказа	Цена ($)
CM188010-10g	in stock	ŭƻœ
CM188010-25g	in stock	Əŭȋ
CM188010-100g	in stock	şşȋ

Только для использования в НИОКР..

Форма запроса

Химическое название

Номер CAS

Количество*

Необходимые спецификации*
(% пробы, категория материала и т.д.)

Контактное лицо*

Электронная почта*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 288148-34-5 regularly via the above email.

Дополнительные примечания

Verification code*

refresh

: Номер CAS:288148-34-5; Молекулярная формула:C4H5ClN2O2S; Точка плавления:-; Smiles-код:O=S(C1=CN(C)N=C1)(Cl)=O; Плотность:

: Номер в каталоге:CM188010; Молекулярная масса:180.61; Точка кипения:; Номер Mdl:MFCD04968667; Хранение:Keep in inert atmosphere, store at 2-8°C.

: Pyrazoles; Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.; Pyrazone; Custom pyrazone for customers from all over the world are our main business.

: Relacorilant; Corcept completes enrollment in phase 3 Gradient trial of Relacorilant in patients with Adrenal Cushing’s Syndrome. Cushing's disease or hypercortisolism is a rare endocrine disorder that occurs when a pituitary adenoma makes excessive cortisol. Cortisol exerts its functions by binding to the glucocorticoid receptor (GR).
Relacorilant is a selective glucocorticoid receptor modulator (SGRM) in clinical development to prevent the effects of high cortisol. Relacorilant is being studied in various serious disorders, including ovarian, adrenal and prostate cancer and Cushing’s syndrome.